European Heart Journal Advance Access published online on March 18, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi171
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Royal Brompton and Harefield NHS Trust, Sydney Street, London SW3 6NP, UK
* To whom correspondence should be addressed. Aims The Euro Heart Survey of Stable Angina set out to prospectively study the presentation and management of patients with stable angina as first seen by a cardiologist in Europe, with particular reference to adherence to existing guidelines and regional variability in patient presentation and initial assessment. Methods and results Consecutive outpatients with a clinical diagnosis by a cardiologist of stable angina were enrolled in the study and 3779 patients were included in the analysis. The average age was 61 years and 58% were male. The majority of patients (88%) had mild to moderate angina, CCS class I or II. Despite a high prevalence of recognized risk factors, 27% did not have cholesterol and 33% did not have glucose measured within 4 weeks of assessment. The resting ECG was abnormal in 41% of patients. An exercise ECG was performed or planned as part of initial investigation in 76% of patients and 18% had a stress imaging test such as perfusion scanning or stress echo. A coronary angiogram was performed or planned in 41%, and 64% had an echo. The time from assessment to investigation varied widely, particularly for angiography. One in 10 patients had neither any form of stress test nor angiography, with marked regional variation. Availability of invasive facilities increased the likelihood of both non-invasive and invasive investigations. Those with more severe symptoms or longer duration of symptoms or a positive non-invasive test were more likely to have angiography. In multivariable analysis, a positive stress test was the strongest predictor of the use of angiography, associated with a six-fold increase in the likelihood of invasive investigation. However, gender and availability of facilities were also predictive. Conclusion Considerable variation in features at presentation and use of investigations has been identified in the stable angina population in Europe. The evaluation of biochemical cardiovascular risk factors was suboptimal. Overall rates of non-invasive investigation for angina and the clinical appropriateness of factors predictive of the use of invasive investigation were broadly in line with guidelines. However, the influence of access to facilities, and marked international variation in rates and timing of investigation suggest that factors unrelated to clinical need are also influential in the management of patients with stable angina.
Received September 15, 2004
Revised January 7, 2005
Accepted January 13, 2005
Clinical research
The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina
2 London School of Hygiene and Tropical Medicine, London, UK
3 Hospital Universitario Gregorio Maranon, Madrid, Spain
4 Policlinico S Matteo, Pavia, Italy
5 Department of Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands
6 Hopital Europeen Georges Pompidou, Paris, France
7 Hopital Cardiovasculaire et Pneumologique Louis Pradel, Lyons, France
8 Herzzentrum Luwigshafen, Ludwigshafen, Germany
9 University of Newcastle upon Tyne, Newcastle upon Tyne, UK
10 Adelaide and Meath incorporating National Children's Hospital, Dublin, Ireland
11 Institute of Cardiology, Warsaw, Poland
12 Aarhus University Hospital, Aarhus, Denmark
13 University Medical Centre St Radboud, Nijmegen, The Netherlands
Caroline A. Daly, E-mail: c.daly{at}rbh.nthames.nhs.uk or carolinenidhal@hotmail.com
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Danchin Still a long way to go to defeating atherosclerotic disease: a call to arms! Eur. Heart J., October 1, 2009; 30(19): 2297 - 2299. [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Beltrame, A. J. Weekes, C. Morgan, R. Tavella, and J. A. Spertus The Prevalence of Weekly Angina Among Patients With Chronic Stable Angina in Primary Care Practices: The Coronary Artery Disease in General Practice (CADENCE) Study Arch Intern Med, September 14, 2009; 169(16): 1491 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sekhri, G. S Feder, C. Junghans, S. Eldridge, A. Umaipalan, R. Madhu, H. Hemingway, and A. D Timmis Incremental prognostic value of the exercise electrocardiogram in the initial assessment of patients with suspected angina: cohort study BMJ, November 13, 2008; 337(nov13_2): a2240 - a2240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Corbett Ethical issues, justification, referral criteria for budget limited and high-dose procedures Radiat Prot Dosimetry, June 1, 2008; 130(2): 125 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M Sibai, R. A Tohme, G. A Saade, G. Ghanem, S. Alam, and for the Lebanese Interventional Coronary Registry The appropriateness of use of coronary angiography in Lebanon: implications for health policy Health Policy Plan., May 1, 2008; 23(3): 210 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Anselmino, J. Ohrvik, K. Malmberg, E. Standl, L. Ryden, and on behalf of the Euro Heart Survey Investigators Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart Eur. Heart J., January 2, 2008; 29(2): 177 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C A Daly, P Hildebrandt, M Bertrand, R Ferrari, W Remme, M Simoons, K M Fox, and on behalf of the EUROPA investigators Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial Heart, November 1, 2007; 93(11): 1406 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Sekhri, G S Feder, C Junghans, H Hemingway, and A D Timmis How effective are rapid access chest pain clinics? Prognosis of incident angina and non-cardiac chest pain in 8762 consecutive patients Heart, April 1, 2007; 93(4): 458 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M J. S Zaman, J. Sanders, A. M Crook, G. Feder, M. Shipley, A. Timmis, and H. Hemingway Cardiothoracic ratio within the "normal" range independently predicts mortality in patients undergoing coronary angiography Heart, April 1, 2007; 93(4): 491 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Steg and D. Tchetche Pharmacologic management of stable angina: role of ivabradine Eur. Heart J. Suppl., September 1, 2006; 8(suppl_D): D16 - D23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Daly, F. Clemens, J. L. Lopez-Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al. The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina Eur. Heart J., June 1, 2006; 27(11): 1298 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stramba-Badiale, K. M. Fox, S. G. Priori, P. Collins, C. Daly, I. Graham, B. Jonsson, K. Schenck-Gustafsson, and M. Tendera Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology Eur. Heart J., April 2, 2006; 27(8): 994 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hemingway, A. McCallum, M. Shipley, K. Manderbacka, P. Martikainen, and I. Keskimaki Incidence and Prognostic Implications of Stable Angina Pectoris Among Women and Men JAMA, March 22, 2006; 295(12): 1404 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sekhri, G.S. Feder, C. Junghans, H. Hemingway, and A.D. Timmis Rapid-access chest pain clinics and the traditional cardiology out-patient clinic QJM, March 1, 2006; 99(3): 135 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A Daly, B. De Stavola, J. L L. Sendon, L. Tavazzi, E. Boersma, F. Clemens, N. Danchin, F. Delahaye, A. Gitt, D. Julian, et al. Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study BMJ, February 4, 2006; 332(7536): 262 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Daly, F. Clemens, J. L. Lopez Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al. Gender Differences in the Management and Clinical Outcome of Stable Angina Circulation, January 31, 2006; 113(4): 490 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Terkelsen and W. Vach Can risk score models help in reducing serious outcome events in patients with stable angina? BMJ, October 15, 2005; 331(7521): 872 - 872. [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Mak Bridging the practice chasm Eur. Heart J., May 2, 2005; 26(10): 949 - 950. [Full Text] [PDF]
|
|
|
|
|
|
C. A. Daly, F. Clemens, J. L. L. Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al. The initial management of stable angina in Europe, from the Euro Heart Survey: A description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina Eur. Heart J., May 2, 2005; 26(10): 1011 - 1022. [Abstract] [Full Text] [PDF]
|
|